Mark Hanson

Title(s)Resource Employee
SchoolUSC Sol Price School of Public Policy
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Implications of treatment duration and frequency for value and cost-effective price of Alzheimer treatments. J Manag Care Spec Pharm. 2024 Oct; 30(10):1087-1094. Mattke S, Ozawa T, Hanson M. PMID: 39037747; PMCID: PMC11424922.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Current Capacity for Diagnosing Alzheimer's Disease in Germany and Implications for Wait Times. J Alzheimers Dis. 2024; 101(4):1249-1259. Mattke S, Tang Y, Hanson M, von Arnim CAF, Frölich L, Grimmer T, Onur OA, Perneczky R, Teipel S, Thyrian JR. PMID: 39302379.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Disparities in Access to Diagnostic Evaluation for Alzheimer's Disease in Individuals Dually Eligible for Medicare and Medicaid: A Modeling Study. J Alzheimers Dis. 2024; 98(4):1403-1414. Mattke S, Jun H, Chu S, Hanson M. PMID: 38517787; PMCID: PMC11758890.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Expected wait times for access to a disease-modifying Alzheimer's treatment in England: A modelling study. J Health Serv Res Policy. 2024 Apr; 29(2):69-75. Mattke S, Tang Y, Hanson M. PMID: 37931615.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment. Alzheimers Dement. 2023 01; 19(1):375-381. Mattke S, Corrêa Dos Santos Filho O, Hanson M, Mateus EF, Neto JPR, de Souza LC, Rizek Schultz R, Pereira Pinto R. PMID: 36063494; PMCID: PMC10087834.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States. Alzheimers Dement. 2022 05; 18(5):1071-1074. Mattke S, Hanson M. PMID: 34569686.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    7. Projection of budgetary savings to US state Medicaid programs from reduced nursing home use due to an Alzheimer's disease treatment. Alzheimers Dement (Amst). 2021; 13(1):e12159. Lam J, Jun H, Cho SK, Hanson M, Mattke S. PMID: 33748394; PMCID: PMC7968122.
      View in: PubMed   Mentions: 5  
    8. Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times. Alzheimers Dement (Amst). 2020; 12(1):e12081. Mattke S, Cho SK, Bittner T, Hlávka J, Hanson M. PMID: 32832590; PMCID: PMC7434228.
      View in: PubMed   Mentions: 29  
    9. Cost and Mortality Implications of Lower Event Rates After Implantation of an Ultrathin-Strut Coronary Stent Compared With a Thin-Strut Stent Over Four Years. Cardiovasc Revasc Med. 2020 07; 21(7):835-842. Mattke S, Hanson M, Bentele M, Kandzari DE. PMID: 31954661.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. Health Economic Evaluation of an Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable-Polymer Everolimus-Eluting Stent. Cardiovasc Revasc Med. 2019 09; 20(9):752-757. Mattke S, Hanson M, Dallmann AC, Bentele M. PMID: 30638888.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Mark's Networks
    Concepts (45)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.